Software and Technology Licenses, Net
Regeneron Pharmaceuticals Software and Technology Licenses, Net increased by 16.9% to $2.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.9%, from $1.39B to $2.13B. Over 5 years (FY 2020 to FY 2025), Software and Technology Licenses, Net shows an upward trend with a 61.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests ongoing investment in technology and digital capabilities, which can drive long-term operational efficiency.
Detailed definition
This represents the capitalized cost of acquired software and technology licenses, net of accumulated amortization. It r...
Peer comparison
Increasingly important across the restaurant sector as companies invest in mobile apps, kiosks, and data analytics.
software_technology_licenses_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $142.90M | $145.90M | $216.10M | $262.00M | $269.90M | $320.20M | $336.40M | $349.60M | $393.20M | $409.90M | $444.10M | $470.20M | $993.80M | $1.04B | $1.14B | $1.39B | $1.54B | $1.67B | $1.82B | $2.13B |
| QoQ Change | — | +2.1% | +48.1% | +21.2% | +3.0% | +18.6% | +5.1% | +3.9% | +12.5% | +4.2% | +8.3% | +5.9% | +111.4% | +5.0% | +8.9% | +22.6% | +10.3% | +8.9% | +8.9% | +16.9% |
| YoY Change | — | — | — | — | +88.9% | +119.5% | +55.7% | +33.4% | +45.7% | +28.0% | +32.0% | +34.5% | +152.7% | +154.5% | +155.8% | +196.3% | +54.6% | +60.4% | +60.3% | +52.9% |
Software and Technology Licenses, Net at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's software and technology licenses, net?
- Regeneron Pharmaceuticals (REGN) reported software and technology licenses, net of $2.13B in Q1 2026.
- How has Regeneron Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Regeneron Pharmaceuticals's software and technology licenses, net increased by 52.9% year-over-year, from $1.39B to $2.13B.
- What is the long-term trend for Regeneron Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's software and technology licenses, net has grown at a 61.0% compound annual growth rate (CAGR), from $168.10M to $1.82B.
- What does software and technology licenses, net mean?
- The net book value of the company's software and technology licenses.